Topline Data Support NDA for Zealand’s Treatment for Rare Childhood Hypoglycemia Disorder
Zealand Pharma will bring a new form of its antihypoglycemia drug Zealogue (dasiglucagon) to the FDA as a potential treatment for children with congenital hyperinsulinism (CHI).
Source: Drug Industry Daily